Is it Worth Retaining ResMed Stock in Your Portfolio Now?

ResMed Inc.’s (RMD) growth in the third quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its progress in digital health technology continues to drive overall revenue growth. However, a dull macroeconomic scenario and fierce competition put pressure on ResMed’s operations. In the past year, shares of this Zacks Rank #3 (Buy) company have surged 15.1%, outperforming the industry’s 8.6% growth and the S&P 500 composite’s 10.1% rise.The renowned medical device company has ...